IL6 and diabetes mellitus: Increased intra-renal FcER1activation in infiltrating mast cells in a patient with diabetes may promote the release of many inflammatory mediators, including TGF-β, TNF-α, IL6, Tryptase, IL1, which can then subsequently drive the development of renal fibrosis.